And the pharmacokinetic research is only one strand of the work the FDA is doing on BPA at its National Center for Toxicological Research in Arkansas and in conjunction with the National Toxicology Program.
FORBES: Leading Environmental Group Scientist Praises FDA's Ground-Breaking Research On BPA: A Tipping Point In The Controversy?